Renasant Bank’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $995K | Buy |
2,453
+916
| +60% | +$371K | 0.66% | 47 |
|
|
2025
Q1 | $765K | Sell |
1,537
-122
| -7% | -$60.7K | 0.51% | 62 |
|
|
2024
Q4 | $863K | Buy |
1,659
+61
| +4% | +$31.7K | 0.56% | 63 |
|
|
2024
Q3 | $988K | Sell |
1,598
-110
| -6% | -$68K | 0.65% | 51 |
|
|
2024
Q2 | $945K | Buy |
1,708
+144
| +9% | +$79.6K | 0.65% | 54 |
|
|
2024
Q1 | $909K | Sell |
1,564
-8
| -0.5% | -$4.65K | 0.65% | 57 |
|
|
2023
Q4 | $834K | Buy |
1,572
+537
| +52% | +$285K | 0.67% | 50 |
|
|
2023
Q3 | $524K | Buy |
1,035
+142
| +16% | +$71.9K | 0.44% | 80 |
|
|
2023
Q2 | $466K | Buy |
+893
| New | +$466K | 0.38% | 84 |
|
|
2022
Q4 | – | Sell |
-475
| Closed | -$241K | – | 191 |
|
|
2022
Q3 | $241K | Sell |
475
-281
| -37% | -$143K | 0.21% | 150 |
|
|
2022
Q2 | $411K | Sell |
756
-23
| -3% | -$12.5K | 0.34% | 99 |
|
|
2022
Q1 | $461K | Buy |
779
+72
| +10% | +$42.6K | 0.31% | 101 |
|
|
2021
Q4 | $471K | Sell |
707
-771
| -52% | -$514K | 0.32% | 98 |
|
|
2021
Q3 | $845K | Sell |
1,478
-200
| -12% | -$114K | 0.67% | 41 |
|
|
2021
Q2 | $847K | Sell |
1,678
-113
| -6% | -$57K | 0.64% | 48 |
|
|
2021
Q1 | $818K | Buy |
1,791
+5
| +0.3% | +$2.28K | 0.66% | 43 |
|
|
2020
Q4 | $832K | Buy |
+1,786
| New | +$832K | 0.68% | 37 |
|